September 8, 2021
Amazon and Blue Origin founder Jeff Bezos is pushing the envelope—on marketing, on suborbital space travel, and now on longevity. He is among a group of investors backing a new anti-aging company, according to a new report obtained by Fox News.
A Russian-born billionaire tech investor, Yuri Milner, and his wife, Julia, also have invested in the company, according to the report. Milner—who is known for investing in companies such as Facebook, Twitter, Spotify and Airbnb—is worth about $4.8 billion, according to Forbes’ estimates.
Altos was incorporated earlier this year in the United States and the United Kingdom; and has plans to create institutes in California, Cambridge, and Japan, according to the report obtained by Fox News.
It’s also reportedly seeking university scientists with deep pockets dedicated to researching how to reverse the process of aging cells.
Bezos’ investment office, Bezos Expeditions, did not immediately respond to Fox News’ request for comment.
However, this isn’t the first time the world’s richest man has invested in this kind of research. The 57-year-old Bezos has also invested in the startup company Unity Biotechnology, the New York Post reported.
Unity, according to its website, is working to develop a “new class of therapeutics to slow, halt, or reverse diseases of aging.”
Representatives for Unity did not immediately respond to Fox News’ request for comment.
Research contact: @FoxNews